Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
David Henley(Janssen (United States)), Gary Romano(Janssen (United States)), Reisa A. Sperling(Harvard University), Rema Raman(University of Southern California), Paul Aisen(University of Southern California), Nandini Raghavan(Janssen (United States))
Cited by 200
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k